Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 121168
Published online Oct 27, 2026. doi: 10.4240/wjgs.121168
Published online Oct 27, 2026. doi: 10.4240/wjgs.121168
Table 2 Comparison of pathological response rates among different treatment regimens, n (%)
| Treatment regimen | Number of patients | pCR (TRG 0) | MPR (TRG 1) | Non-MPR (TRGs 2 and 3) | Overall pathological response rate (TRGs 0 and 1) | χ2 | P value |
| Immunotherapy monotherapy | 53 | 6 (11.3) | 11 (20.8) | 36 (67.9) | 17 (32.1) | 10.362 | < 0.001 |
| Combination immunotherapy | 77 | 24 (31.2) | 20 (25.9) | 33 (42.9) | 44 (57.1) | ||
| Total | 130 | 30 (23.1) | 31 (23.8) | 69 (53.1) | 61 (46.9) |
- Citation: Zhang K, Li ZJ. Correlation between pathological response to neoadjuvant immunotherapy and long-term survival in locally advanced rectal cancer: A real-world study. World J Gastrointest Surg 2026; 18(10): 121168
- URL: https://www.wjgnet.com/1948-9366/full/v18/i10/121168.htm
- DOI: https://dx.doi.org/10.4240/wjgs.121168